Sign in

You're signed outSign in or to get full access.

Jackie Plesset

SMID Cap Biotech Equity Research Associate at Bank of America

Jackie Plesset is a SMID Cap Biotech Equity Research Associate at Bank of America, specializing in small- and mid-cap biotechnology companies. She focuses on equity research within the biotech sector, though specific companies covered and detailed performance metrics such as success rates or returns on platforms like TipRanks are not publicly available in current sources. Plesset is based in the United States and currently holds this role at Bank of America, with no detailed career timeline, previous firms, or notable achievements identified; professional credentials including FINRA registrations or securities licenses are also not specified in available information.

Jackie Plesset's questions to CYTOKINETICS (CYTK) leadership

Question · Q4 2025

Jackie Plesset, on behalf of Jason Zemansky, asked for an update on patient start forms thus far this year and the extent of early efforts involving community practices, including their reception.

Answer

Andrew Callos, EVP and CCO, and Robert Blum, President and CEO, declined to provide specific numbers for start forms but indicated that demand and physician engagement are at or above internal expectations. They noted strong engagement from both centers of excellence and community practices, including new CMI prescribers.

Ask follow-up questions

Fintool

Fintool can predict CYTOKINETICS logo CYTK's earnings beat/miss a week before the call

Question · Q4 2025

Jackie Plesset inquired about the number of patient start forms received thus far this year and the extent and reception of early commercial efforts within community practices.

Answer

EVP and Chief Commercial Officer Andrew Callos stated that specific numbers for patient start forms would be reported in Q1, but noted that demand and physician engagement are at or above internal expectations. He added that while the majority of engagement is with high-volume prescribers, there's strong and higher-than-expected engagement from community practices and new prescribers.

Ask follow-up questions

Fintool

Fintool can write a report on CYTOKINETICS logo CYTK's next earnings in your company's style and formatting